We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Immunoassays – Webinars and Online Events

Cytvia Lateral Flow
Webinar

Lateral Flow Assays: Test Development, Optimization and Troubleshooting

On-Demand
Join our webinar, hosted by Klaus Hochleitner, to discuss key considerations for lateral flow test development and optimization and troubleshooting techniques for different samples, tests and antibodies.
Cytiva webinar hosted by Technology Networks, being held on September 27, 2023
Webinar

Lateral Flow Assays: Discover the Importance of the Nitrocellulose Membrane

On-Demand
The nitrocellulose membrane (NC) is the heart of a lateral flow assay. It is where the target and control molecules are captured and where the test results are read.
Join our webinar, hosted by Klaus Hochleitner, to take a deep dive into nitrocellulose membranes including the raw material, structure manufacturing process and capillary flow time and how these affect your lateral flow assays.
Klaus will also cover the effect of surfactants on protein binding and membrane properties and how to deal with unspecific binding of proteins to nitrocellulose membranes.
Cell and Gene Therapy 2023
Webinar

Products & Services Across Cell Therapy Research & Development

On-Demand
Speaking at Cell & Gene Therapy 2023,Tracy Zhao from ACROBiosystems, presented their talk on products and services across cell therapy research and development.
Ella: Next Generation Analysis for Your Cell Therapy Workflow
Webinar

Ella: Next Generation Analysis for Your Cell Therapy Workflow

On-Demand
Speaking at Cell and Gene Therapy 2023, Habib Malik from Bio-Techne, presented their talk on reproducible and easy-to-use immunoassay platforms.
How to Select and Validate Host Cell Proteins for Process Development content piece image
Webinar

How to Select and Validate Host Cell Proteins for Process Development

On-Demand
Off-the-shelf generic and commercial Chinese hamster ovaries (CHO) host cell proteins (HCP) ELISAs are commonly used to quantitate HCP in early process development. However, it’s challenging to find and choose a generic ELISA suited to a process.
Generation and Validation of CHO HCP ELISA content piece image
Webinar

Generation and Validation of CHO HCP ELISA

On-Demand
In bioprocessing, it is critical that host cell proteins (HCPs) can be identified, detected and removed so that the efficacy of the drug is not impacted, and custom process-specific HCP ELISA are typically the preferred method for measuring these contaminants.
Opportunities and Challenges of Blood-Based Biomarkers in Alzheimer's Disease content piece image
Webinar

Opportunities and Challenges of Blood-Based Biomarkers in Alzheimer's Disease

On-Demand
In this webinar, our expert speaker, Professor Lei Liu, Assistant Professor of Neurology from Harvard Medical School will discuss strategies in developing an ultrasensitive immunoassay* to measure oligomeric amyloid β in human plasma precisely.
Introducing Stellar: High-Sensitivity Fluorescence Multiplexing for Western Workflows content piece image
Webinar

Introducing Stellar: High-Sensitivity Fluorescence Multiplexing for Western Workflows

On-Demand
Traditional Western blot workflows are notoriously labor-intensive and limited in reproducibility, quantification, sensitivity and multiplexing capabilities.
Formulating Cannabinoid Particles for Therapeutics content piece image
Webinar

Formulating Cannabinoid Particles for Therapeutics

On-Demand
Join Dr Natalia Sannikova and Tomas Skrinskas from Ascension Sciences, as they explore the therapeutic use of cannabinoids as novel medicines and the opportunities of nanotechnology in formulating cannabinoid nanoparticles.
Analysis of Process Related Impurities in Cell & Gene Therapy Products by SWATH LC-MS content piece image
Webinar

Analysis of Process Related Impurities in Cell & Gene Therapy Products by SWATH LC-MS

On-Demand
The manufacturing process for cell and gene therapies is complex and can contain process-related impurities from multiple organisms. A commercial host cell protein (HCP)-ELISA kit is often not available for the cell line or is not suitable for the specific process due to a low HCP coverage. Development of a process-specific ELISA can be unfeasible as the product often requires a short development time.
Advertisement